These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2301404)

  • 41. Present state of DNA-diagnosis for cystic fibrosis and attitudes concerning a heterozygote screening in the GDR.
    Coutelle C; Grade K; Speer A; Will K; Gille C; Szibor R; Gedschold J; Brückner R; Steinbicker V; Bauer I
    Adv Exp Med Biol; 1991; 290():75-8; discussion 78-81. PubMed ID: 1950759
    [No Abstract]   [Full Text] [Related]  

  • 42. Cystic fibrosis screening at the Greenville Hospital System.
    Dacus J; Mabie B; Gailey T; Rogers C; Likes C; Metcalf L
    J S C Med Assoc; 2006 Feb; 102(1):14-6. PubMed ID: 16704181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PCR-based cystic fibrosis (CF) carrier screening in a first-year medical student biochemistry laboratory.
    Grody WW; Kronquist KE; Lee EU; Edmond J; Rome LH
    Am J Hum Genet; 1993 Dec; 53(6):1352-5. PubMed ID: 8250051
    [No Abstract]   [Full Text] [Related]  

  • 44. Update on MSAFP policy statement from the American Society of Human Genetics.
    Garver KL
    Am J Hum Genet; 1989 Aug; 45(2):332-4. PubMed ID: 2474250
    [No Abstract]   [Full Text] [Related]  

  • 45. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
    Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
    Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening and the new genetics.
    Cooper JD; Franks AJ
    J Public Health Med; 1997 Mar; 19(1):121. PubMed ID: 9138228
    [No Abstract]   [Full Text] [Related]  

  • 47. A case for cystic fibrosis carrier testing in the general population.
    McClaren BJ; Metcalfe SA; Amor DJ; Aitken M; Massie J
    Med J Aust; 2011 Feb; 194(4):208-9. PubMed ID: 21401469
    [No Abstract]   [Full Text] [Related]  

  • 48. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antenatal cystic fibrosis carrier screening--whether, when and how?
    Miedzybrodzka Z; Haites N; Hall M; Templeton A; Marteau T; Dean J; Kelly K; Russell I
    Paediatr Perinat Epidemiol; 1993 Oct; 7(4):368-75. PubMed ID: 8290376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antenatal screening for cystic fibrosis: a trial of the couple model.
    Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
    BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Willingness to pay for antenatal carrier screening for cystic fibrosis.
    Donaldson C; Shackley P; Abdalla M; Miedzybrodzka Z
    Health Econ; 1995; 4(6):439-52. PubMed ID: 8653184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Universal community carrier screening for cystic fibrosis?
    Williamson R
    Nat Genet; 1993 Mar; 3(3):195-201. PubMed ID: 8485573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice.
    Elias S; Annas GJ; Simpson JL
    Am J Obstet Gynecol; 1991 Apr; 164(4):1077-83. PubMed ID: 2014829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosis.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Van den Berghe H
    Clin Genet; 1992 Apr; 41(4):189-96. PubMed ID: 1576756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Wilcken B
    J Paediatr Child Health; 2008 Apr; 44(4):232-3; author reply 233. PubMed ID: 18377372
    [No Abstract]   [Full Text] [Related]  

  • 56. Pros and cons of neonatal screening for cystic fibrosis.
    te Meerman GJ; Dankert-Roelse JE
    Adv Exp Med Biol; 1991; 290():83-92; discussion 92-5. PubMed ID: 1950760
    [No Abstract]   [Full Text] [Related]  

  • 57. Automation and the single-gene disorder: cystic fibrosis as a model.
    Silverman LM; Highsmith WE
    Clin Chem; 1992 Jan; 38(1):7-8. PubMed ID: 1733609
    [No Abstract]   [Full Text] [Related]  

  • 58. ACOG Committee Opinion. Number 325, December 2005. Update on carrier screening for cystic fibrosis.
    Committee on Genetics, American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2005 Dec; 106(6):1465-8. PubMed ID: 16319281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A cost-effectiveness analysis of prenatal carrier screening for cystic fibrosis.
    Vintzileos AM; Ananth CV; Smulian JC; Fisher AJ; Day-Salvatore D; Beazoglou T
    Obstet Gynecol; 1998 Apr; 91(4):529-34. PubMed ID: 9540935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening and the new genetics; a public health perspective on the ethical debate.
    Stone DH; Stewart S
    J Public Health Med; 1996 Mar; 18(1):3-5. PubMed ID: 8785072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.